Eisai GmbH

Edmund-Rumpler-Str. 3, Frankfurt Am Main, Hessen, Germany

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 4

16.7%

Trial Status Distribution

Active, not recruiting

16.7%

Completed

66.7%

Terminated

16.7%

Clinical Trials

Trials sponsored by this organization (6)

A Study to Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic Seizures

Completed

observational

Jan 2020187 participants

Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization

Phase 4

Terminated

interventional

May 2005157 participants

Randomized trial to assess efficacy and safety of an add-on treatment with zonisamide in adults with focal epileptic seizures with or without secondary generalizatio

Active, not recruiting

Feb 2005

Approvals

Approvals by Agency

EMA

European Medicines Agency

Approvals

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

Approvals

Recent Approvals

FYCOMPA 6 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

CIMA_AEMPS

2026-09-16

LENVIMA 4 MG CAPSULAS DURAS

CIMA_AEMPS

2026-07-07

LEQEMBI 100 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

FYCOMPA 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

CIMA_AEMPS

2022-01-21

FYCOMPA 6 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

CIMA_AEMPS

2022-01-21

FYCOMPA 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

CIMA_AEMPS

2022-01-21

ZONEGRAN 100 mg CAPSULAS DURAS

CIMA_AEMPS

2020-05-08

News

No news articles found

Back to Organizations

Eisai GmbH

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (6)

A Study to Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic Seizures

Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy

Incidence and Resolution of Eribulin-induced peripheral Neuropathy (IRENE)

ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization

Randomized trial to assess efficacy and safety of an add-on treatment with zonisamide in adults with focal epileptic seizures with or without secondary generalizatio

Approvals

Approvals by Agency

Recent Approvals

News